These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23334072)

  • 1. First case of lacosamide-induced psychosis.
    Chatzistefanidis D; Karvouni E; Kyritsis AP; Markoula S
    Clin Neuropharmacol; 2013; 36(1):27-8. PubMed ID: 23334072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacosamide Induced Psychosis: Case Report, Review of Differential Diagnosis and Relevant Pharmacokinetics.
    Pinkhasov A; Lam T; Hayes D; Friedman M; Singh D; Cohen H
    Clin Neuropharmacol; 2015; 38(5):198-200. PubMed ID: 26366962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trials.
    Zaccara G; Perucca P; Loiacono G; Giovannelli F; Verrotti A
    Epilepsia; 2013 Jan; 54(1):66-74. PubMed ID: 22779776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.
    Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C
    Seizure; 2018 May; 58():141-146. PubMed ID: 29704679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy.
    IJff DM; van Veenendaal TM; Majoie HJ; de Louw AJ; Jansen JF; Aldenkamp AP
    Acta Neurol Scand; 2015 Jun; 131(6):347-54. PubMed ID: 25630655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide-induced rash.
    Koubeissi MZ; Vismer M; Ehrlich A
    Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide: new adjunctive treatment option for partial-onset seizures.
    Chung SS
    Expert Opin Pharmacother; 2010 Jun; 11(9):1595-602. PubMed ID: 20482307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?
    Novy J; Patsalos PN; Sander JW; Sisodiya SM
    Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of lacosamide-induced hepatotoxicity.
    Sunwoo JS; Byun JI; Lee SK
    Int J Clin Pharmacol Ther; 2015 Jun; 53(6):471-3. PubMed ID: 25907173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy.
    Nizam A; Mylavarapu K; Thomas D; Briskin K; Wu B; Saluja D; Wong S
    Epilepsia; 2011 Oct; 52(10):e153-5. PubMed ID: 21801173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adjunctive lacosamide on mood and quality of life in patients with epilepsy.
    Nakhutina L; Kunnakkat SD; Coleman M; Lushbough C; Arnedo V; Soni N; Grant AC
    Epilepsy Behav; 2017 Aug; 73():90-94. PubMed ID: 28623755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide, a newer antiepileptic.
    Patyar S; Medhi B
    Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures.
    Degiorgio CM
    Epilepsy Behav; 2010 Jul; 18(3):322-4. PubMed ID: 20570216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary efficacy and safety of lacosamide in children with refractory epilepsy.
    Heyman E; Lahat E; Levin N; Berkovitch M; Gandelman-Marton R
    Eur J Paediatr Neurol; 2012 Jan; 16(1):15-9. PubMed ID: 21924653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.